- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
CGC
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
Canopy Growth Corp · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
0.89 USD
-5.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -16.3% below the Trend Line and sits at 2.9% of its 52-week range. The latest completed week returned -5.5%, after a -6.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 40/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 15d.
Setup score
12
out of 100
Latest Close
0.89 USD
24 Jul 2026
1W Return
-5.5%
latest completed week
4W Return
-6.1%
short-term follow-through
12W Return
-21.4%
quarterly tape
Trend Breadth
15.4%
8 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-5.5%
Latest completed week; four-week move -6.1%.
Indicator stack
8/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.99%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
40/100 conviction; expected move 13.5%.
News sentiment
57/100
55 relevant articles in the latest sentiment read.
Event risk
15d
Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -16.3% below the Trend Line and sits at 2.9% of its 52-week range. The latest completed week returned -5.5%, after a -6.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0212-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -6.1% over four weeks, -21.4% over 12 weeks, and -22.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.64Latest activity-pressure read.
Pressure change-1404.2%Four-week change in activity pressure.
Leadership-30.89Latest relative-leadership reading.
RS change-0.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 82%
Model confidence 78%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength34/100Blend of value, momentum, and quality. Underlying universe rank 67; rank 1 is best.
Value74/100Relative valuation strength. Underlying universe rank 27; rank 1 is best.
Quality7/100Profitability and accounting quality. Underlying universe rank 94; rank 1 is best.
Momentum15/100Medium-term price momentum. Underlying universe rank 86; rank 1 is best.
Growth77/100Revenue and earnings growth. Underlying universe rank 24; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 1.2x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -22.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 24.9% Gross profit retained from each unit of revenue.
- Operating margin
- -78.5% Operating profit retained from revenue.
- Free-cash-flow margin
- -20.4% Free cash flow generated from revenue.
- Return on invested capital
- -30.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 16.1% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -99.7% Net share repurchases relative to market value.
- Shareholder yield
- -99.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
CGC shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.65, expected move of 13.5%, and Sharemaestro trend signal inactive.
Conviction40/100
Expected move13.5%
Put/call volume0.65
Insider activity10 / 7
10 acquisitions and 7 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment57/100
Weighted news tone is neutral across 55 relevant articles.
31 positive · 18 neutral · 6 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings15dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
Options expected move13.5%Nearest-chain priced movement where available.
52-week drawdown-62.7%Distance below the 52-week high.
13-week volatility3.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher8 of 2617 weeks finished lower.
Best week+11.9%Week of 3 Apr.
Worst week-8.4%Week of 30 Jan.
Latest week-5.5%Week of 24 Jul.
Shape of recent returns
Strong gains6
Modest gains2
Flat weeks1
Modest losses7
Sharp losses10
Recent vol3.6%13-week weekly-return volatility.
Base vol11.5%52-week weekly-return volatility.
Up/down split17/30Count of positive and negative weeks in the 52-week window.
Average skew10.9% / -6.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Drug Manufacturers - Specialty & Generic
4-week rank46 / 74
Group average-1.2%
Trend breadth37.8%
Trend37.8%active weekly trend signals
MD59.5%positive activity pressure
RS33.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape11/100
Trend, activity pressure, participation, and risk combine to a 11/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.02; No reversal markers Next-Week ExpectancyNegative 36.99%Next-week expectancy is negative with a 36.99% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors31/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 100; Small Cap Core rank 41 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options51/100CGC shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.65, expected move of 13.5%, and Sharemaestro trend signal inactive.
Bullish · Call-side pressure · Expected move 13.5% Sentiment57/100Weighted news tone is neutral across 55 relevant articles.
Canopy Growth Corp (CGC) Dividends & Stock Splits: Historical Payouts and Event Timeline Insiders10 / 710 acquisitions and 7 disposals in the latest 180-day insider tape.
Earnings15dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 0.89 USD | -5.5% | 1.06 USD | 3.48 USD | -0.64 | -30.89 | 10.5M | Off |
| 17 Jul 2026 | 0.94 USD | -3.2% | 1.07 USD | 3.50 USD | -0.35 | -28.59 | 9.8M | Off |
| 10 Jul 2026 | 0.97 USD | -2.9% | 1.09 USD | 3.52 USD | -0.10 | -29.71 | 14.0M | Off |
| 3 Jul 2026 | 1.00 USD | 5.7% | 1.11 USD | 3.54 USD | 0.05 | -26.84 | 31.6M | Off |
| 26 Jun 2026 | 0.95 USD | -2.2% | 1.12 USD | 3.56 USD | 0.05 | -30.83 | 18.1M | Off |
| 19 Jun 2026 | 0.97 USD | -3.3% | 1.13 USD | 3.58 USD | 0.19 | -33.05 | 31.0M | Off |
| 12 Jun 2026 | 1.00 USD | -2.9% | 1.13 USD | 3.61 USD | 0.28 | -29.66 | 34.4M | Off |
| 5 Jun 2026 | 1.03 USD | -5.5% | 1.13 USD | 3.64 USD | 0.32 | -26.90 | 35.6M | Off |
| 29 May 2026 | 1.09 USD | 4.8% | 1.14 USD | 3.68 USD | 0.41 | -27.36 | 32.6M | Off |
| 22 May 2026 | 1.04 USD | 0.0% | 1.14 USD | 3.73 USD | 0.48 | -29.40 | 41.3M | Off |
| 15 May 2026 | 1.04 USD | -6.3% | 1.15 USD | 3.77 USD | 0.69 | -29.96 | 35.1M | Off |
| 8 May 2026 | 1.11 USD | -1.8% | 1.16 USD | 3.84 USD | 0.69 | -26.65 | 29.1M | Off |
| 1 May 2026 | 1.13 USD | -4.6% | 1.17 USD | 3.90 USD | 0.48 | -22.02 | 50.4M | Off |
| 24 Apr 2026 | 1.19 USD | 3.9% | 1.18 USD | 3.98 USD | 0.06 | -17.74 | 164.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.